US 9828435
Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9828435 (Use of antibodies or antigen-binding fragments thereof that specifically bind semaphorin-4D to increase tumor infiltrating leukocyte frequency) held by VACCINEX, INC. expires Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VACCINEX, INC.
- Grant date
- Tue Nov 28 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 23 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K2039/54, A61K2039/545